Year To Quarter End Consolidated Statement Of Income

Kidswell Bio Corporation - Filing #7324937

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Year to quarter end consolidated statement of income
Statement of income
Net sales
2,431,236,000 JPY
2,776,241,000 JPY
Cost of sales
1,391,852,000 JPY
1,250,553,000 JPY
Gross profit (loss)
1,039,383,000 JPY
1,525,688,000 JPY
Selling, general and administrative expenses
Depreciation
917,000 JPY
928,000 JPY
Selling, general and administrative expenses
2,374,980,000 JPY
2,076,617,000 JPY
Operating profit (loss)
-1,335,597,000 JPY
-550,929,000 JPY
Non-operating income
Interest income
8,000 JPY
12,000 JPY
Non-operating income
6,785,000 JPY
3,980,000 JPY
Non-operating expenses
Interest expenses
35,651,000 JPY
32,760,000 JPY
Non-operating expenses
60,789,000 JPY
77,820,000 JPY
Ordinary profit (loss)
-1,389,601,000 JPY
-624,769,000 JPY
Extraordinary income
Extraordinary income
4,074,000 JPY
JPY
Extraordinary losses
Extraordinary losses
35,000,000 JPY
31,454,000 JPY
Profit (loss) before income taxes
-1,420,527,000 JPY
-656,224,000 JPY
Income taxes - current
1,551,000 JPY
1,210,000 JPY
Income taxes
1,551,000 JPY
1,210,000 JPY
Profit (loss)
-1,422,078,000 JPY
-1,422,078,000 JPY
-1,422,078,000 JPY
-1,422,078,000 JPY
-657,434,000 JPY
-657,434,000 JPY
-657,434,000 JPY
-657,434,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.